Since cancer cells are adept at engaging available metabolic flexibility mechanisms, we hypothesized that noncanonical acetyl-CoA production mechanisms could be revealed by developing ACLY KO cancer cell models that are not dependent on acetate for viability. The gene discussed is ACLY; the disease is cancer.